Description
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens
$239.89
Polyclonal Antibodies
Weight | 3 lbs |
---|---|
Dimensions | 5 × 5 × 5 in |
Manufacturer | |
Size/Quantity | |
Product Size | |
Shipping Condition | |
Manufacturer Part No |
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens